L
Link Pharma Chem Limited
BSE:524748
Link Pharma Chem Limited
BSE:524748
Price:
29
INR
7.41%
Market Closed
Market Cap:
₹128.8m
Balance Sheet
Balance Sheet Decomposition
Link Pharma Chem Limited
Link Pharma Chem Limited
Balance Sheet Decomposition is not available for
Link Pharma Chem Limited
Link Pharma Chem Limited
Balance Sheet
Link Pharma Chem Limited
Link Pharma Chem Limited
Currency: INR
| Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
2
|
7
|
1
|
2
|
2
|
12
|
3
|
2
|
2
|
2
|
21
|
49
|
9
|
2
|
1
|
1
|
|
| Cash Equivalents |
1
|
1
|
2
|
7
|
1
|
2
|
2
|
12
|
3
|
2
|
2
|
2
|
21
|
49
|
9
|
2
|
1
|
1
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Receivables |
34
|
47
|
33
|
44
|
35
|
36
|
33
|
31
|
23
|
22
|
32
|
31
|
50
|
56
|
54
|
37
|
52
|
50
|
|
| Accounts Receivables |
26
|
38
|
22
|
28
|
24
|
32
|
33
|
31
|
23
|
22
|
32
|
30
|
50
|
56
|
54
|
36
|
52
|
50
|
|
| Other Receivables |
9
|
9
|
11
|
16
|
11
|
4
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
0
|
|
| Inventory |
18
|
16
|
32
|
36
|
38
|
53
|
55
|
38
|
37
|
43
|
26
|
29
|
16
|
25
|
48
|
123
|
62
|
57
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
4
|
5
|
3
|
5
|
5
|
5
|
9
|
3
|
21
|
25
|
14
|
1
|
3
|
|
| Total Current Assets |
53
|
65
|
67
|
86
|
74
|
95
|
95
|
83
|
67
|
72
|
66
|
72
|
91
|
151
|
136
|
175
|
115
|
112
|
|
| PP&E Net |
109
|
108
|
121
|
138
|
154
|
154
|
165
|
175
|
101
|
96
|
98
|
96
|
88
|
87
|
90
|
90
|
99
|
93
|
|
| PP&E Gross |
109
|
108
|
121
|
138
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
41
|
34
|
39
|
43
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
3
|
0
|
1
|
5
|
7
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
4
|
7
|
52
|
48
|
42
|
24
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
1
|
0
|
0
|
2
|
7
|
15
|
11
|
11
|
3
|
4
|
|
| Total Assets |
163
N/A
|
173
+6%
|
189
+9%
|
224
+19%
|
230
+3%
|
251
+9%
|
264
+5%
|
265
+1%
|
173
-35%
|
171
-1%
|
172
+0%
|
180
+5%
|
190
+5%
|
260
+37%
|
290
+11%
|
325
+12%
|
260
-20%
|
233
-10%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
24
|
20
|
42
|
28
|
27
|
30
|
34
|
34
|
30
|
68
|
48
|
66
|
18
|
35
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
42
|
40
|
42
|
33
|
33
|
2
|
7
|
0
|
5
|
26
|
58
|
78
|
51
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
3
|
3
|
4
|
1
|
9
|
10
|
3
|
2
|
|
| Other Current Liabilities |
18
|
33
|
36
|
37
|
40
|
33
|
17
|
24
|
6
|
4
|
5
|
6
|
1
|
19
|
24
|
11
|
11
|
12
|
|
| Total Current Liabilities |
18
|
33
|
36
|
37
|
64
|
95
|
100
|
94
|
70
|
70
|
44
|
49
|
35
|
93
|
106
|
145
|
110
|
101
|
|
| Long-Term Debt |
52
|
49
|
54
|
88
|
62
|
48
|
51
|
58
|
18
|
12
|
22
|
17
|
32
|
32
|
29
|
20
|
11
|
4
|
|
| Deferred Income Tax |
9
|
9
|
7
|
6
|
6
|
6
|
7
|
0
|
2
|
4
|
8
|
10
|
9
|
9
|
9
|
7
|
2
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
30
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
2
|
0
|
2
|
|
| Total Liabilities |
79
N/A
|
91
+15%
|
97
+8%
|
131
+34%
|
132
+1%
|
150
+14%
|
157
+5%
|
182
+16%
|
90
-51%
|
85
-5%
|
74
-13%
|
76
+3%
|
75
-1%
|
135
+79%
|
145
+7%
|
174
+20%
|
122
-30%
|
106
-13%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
|
| Retained Earnings |
40
|
38
|
47
|
49
|
54
|
57
|
62
|
39
|
39
|
42
|
53
|
59
|
70
|
81
|
100
|
106
|
93
|
82
|
|
| Total Equity |
84
N/A
|
83
-2%
|
91
+11%
|
94
+3%
|
99
+5%
|
102
+3%
|
107
+5%
|
84
-22%
|
84
+0%
|
86
+3%
|
98
+14%
|
104
+6%
|
114
+10%
|
126
+10%
|
145
+15%
|
150
+4%
|
137
-9%
|
127
-8%
|
|
| Total Liabilities & Equity |
163
N/A
|
173
+6%
|
189
+9%
|
224
+19%
|
230
+3%
|
251
+9%
|
264
+5%
|
265
+1%
|
173
-35%
|
171
-1%
|
172
+0%
|
180
+5%
|
190
+5%
|
260
+37%
|
290
+11%
|
325
+12%
|
260
-20%
|
233
-10%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
